scholarly journals Secondary analysis of electronically monitored medication adherence data for a cohort of hypertensive African-Americans

2012 ◽  
pp. 207 ◽  
Author(s):  
George Knafl ◽  
Schoenthaler ◽  
Ogedegbe
Keyword(s):  
Medication Adherence ◽  
African Americans ◽  
Secondary Analysis ◽  
Adherence Data

scholarly journals Glaucoma Medication Adherence among African Americans

2013 ◽  
Vol 90 (8) ◽  
pp. 883-897 ◽  
Author(s):  
Laura E. Dreer ◽  
Christopher A. Girkin ◽  
Lisa Campbell ◽  
Andy Wood ◽  
Liyan Gao ◽  
...  
Keyword(s):  
Medication Adherence ◽  
African Americans ◽  
Glaucoma Medication

scholarly journals Goals-of-Care Consult and Future Costs, Acute Care and Hospice Use in Matched Cohorts of African Americans and Whites

2020 ◽  
Vol 4 (Supplement_1) ◽  
pp. 521-521
Author(s):  
Lauren Starr ◽  
Connie Ulrich ◽  
Scott Appel ◽  
Paul Junker ◽  
Nina O’Connor ◽  
...  
Keyword(s):  
African Americans ◽  
End Of Life ◽  
Acute Care ◽  
Secondary Analysis ◽  
Care Utilization ◽  
Goals Of Care ◽  
Palliative Care Consultation ◽  
Significant Difference ◽  
Hospice Use ◽  
Care Costs

Abstract African Americans receive less hospice care and more aggressive end-of-life care than Whites. Little is known about how palliative care consultation to discuss goals-of-care (“PCC”) is associated with future acute care utilization and costs, or hospice use, by race. To compare future acute care costs and utilization and discharge to hospice between propensity-matched cohorts of African Americans with and without PCC, and Whites with and without PCC, we conducted a secondary analysis of 35,154 seriously-ill African American and White adults who had PCC at a high-acuity hospital and were discharged 2014-2016. We found no significant difference between African Americans with or without PCC in mean future acute care costs ($11,651 vs. $15,050, P=0.09), 30-day readmissions (P=0.58), future hospital days (P=0.34), future ICU admission (P=0.25), or future ICU days (P=0.30), but found greater discharge to hospice among African Americans with PCC (36.5% vs. 2.4%, P<0.0001). We found significant differences between Whites with PCC vs. without PCC in mean future acute care costs ($8,095 vs. $16,799, P<0.001), 30-day readmissions (10.2% vs. 16.7%, P<0.0001), future days hospitalized (3.7 vs. 6.3 days, P<0.0001), and discharge to hospice (42.7% vs. 3.0%, P<0.0001). Results suggest PCC decreases future acute care costs and utilization in Whites and, directionally but not significantly, in African Americans; and increases discharge to hospice in both races (15-fold in African Americans, 14-fold in Whites). Research is needed to understand how PCC supports end-of-life decision-making and hospice use across races and how systems and policies can enable effective goals-of-care consultations across settings.

scholarly journals CHEMICAL RENAL DENERVATION WITH ALCOHOL – THE POST-MARKET STUDY MEDICATION ADHERENCE DATA

2019 ◽  
Vol 37 ◽  
pp. e283
Author(s):  
A. Persu ◽  
S.W. Toennes ◽  
S. Ritscher ◽  
C.M.G. Georges ◽  
P. Wallemacq ◽  
...  
Keyword(s):  
Medication Adherence ◽  
Renal Denervation ◽  
Study Medication ◽  
Post Market ◽  
Adherence Data

scholarly journals Patient and clinician perspectives on optimizing graphical displays of longitudinal medication adherence data

2019 ◽  
Vol 102 (6) ◽  
pp. 1090-1097 ◽  
Author(s):  
Allison P. Pack ◽  
Carol E. Golin ◽  
Lauren M. Hill ◽  
Jessica Carda-Auten ◽  
Deshira D. Wallace ◽  
...  
Keyword(s):  
Medication Adherence ◽  
Graphical Displays ◽  
Adherence Data ◽  
Clinician Perspectives

An Examination of John Henryism, Trust, and Medication Adherence Among African Americans With Hypertension

2019 ◽  
Vol 47 (1) ◽  
pp. 162-169
Author(s):  
Yendelela L. Cuffee ◽  
Lee Hargraves ◽  
Milagros Rosal ◽  
Becky A. Briesacher ◽  
Jeroan J. Allison ◽  
...  
Keyword(s):  
Medication Adherence ◽  
African Americans ◽  
Confidence Interval ◽  
Health Behaviors ◽  
Safety Net ◽  
The Body ◽  
John Henryism ◽  
Point Increase ◽  
Safety Net Hospital ◽  
Using Data

Background. John Henryism is defined as a measure of active coping in response to stressful experiences. John Henryism has been linked with health conditions such as diabetes, prostate cancer, and hypertension, but rarely with health behaviors. Aims. We hypothesized that reporting higher scores on the John Henryism Scale may be associated with poorer medication adherence, and trust in providers may mediate this relationship. Method. We tested this hypothesis using data from the TRUST study. The TRUST study included 787 African Americans with hypertension receiving care at a safety-net hospital. Ordinal logistic regression was used to examine the relationship between John Henryism and medication adherence. Results. Within our sample of African Americans with hypertension, lower John Henryism scores was associated with poorer self-reported adherence (low, 20.62; moderate, 19.19; high, 18.12; p < .001). Higher John Henryism scores were associated with lower trust scores (low John Henryism: 40.1; high John Henryism: 37.9; p < .001). In the adjusted model, each 1-point increase in the John Henryism score decreased the odds of being in a better cumulative medication adherence category by a factor of 4% (odds ratio = 0.96, p = .014, 95% confidence interval = 0.93-0.99). Twenty percent of the association between medication adherence and John Henryism was mediated by trust (standard deviation = 0.205, 95% confidence interval = 0.074-0.335). Discussion. This study provides important insights into the complex relationship between psychological responses and health behaviors. It also contributes to the body of literature examining the construct of John Henryism among African Americans with hypertension. Conclusion. The findings of this study support the need for interventions that promote healthful coping strategies and patient–provider trust.

scholarly journals Current State and Future Trends to Optimize the Care of Chronic Kidney Disease in African Americans

2017 ◽  
Vol 46 (2) ◽  
pp. 176-186 ◽  
Author(s):  
Kimberly Harding ◽  
Tesfaye B. Mersha ◽  
Joseph A. Vassalotti ◽  
Fern J. Webb ◽  
Susanne B. Nicholas
Keyword(s):  
Chronic Kidney Disease ◽  
Medication Adherence ◽  
African Americans ◽  
Kidney Disease ◽  
Kidney Failure ◽  
Social Determinant ◽  
Assessment Tools ◽  
Improve Medication Adherence ◽  
Outreach Programs ◽  
Caucasian Americans

Background: African Americans (AAs) suffer the widest gaps in chronic kidney disease (CKD) outcomes compared to Caucasian Americans (CAs) and this is because of the disparities that exist in both health and healthcare. In fact, the prevalence of CKD is 3.5 times higher in AAs compared to CAs. The disparities exist at all stages of CKD. Importantly, AAs are 10 times more likely to develop hypertension-related kidney failure and 3 times more likely to progress to kidney failure compared to CAs. Summary: Several factors contribute to these disparities including genetic and social determinants, late referrals, poor care coordination, medication adherence, and low recruitment in clinical trials. Key Messages: The development and implementation of CKD-related evidence-based approaches, such as clinical and social determinant assessment tools for medical interventions, more widespread outreach programs, strategies to improve medication adherence, safe and effective pharmacological treatments to control or eliminate CKD, as well as the use of health information technology, and patient-engagement programs for improved CKD outcomes may help to positively impact these disparities among AAs

scholarly journals Reported Racial Discrimination, Trust in Physicians, and Medication Adherence Among Inner-City African Americans With Hypertension

2013 ◽  
Vol 103 (11) ◽  
pp. e55-e62 ◽  
Author(s):  
Yendelela L. Cuffee ◽  
J. Lee Hargraves ◽  
Milagros Rosal ◽  
Becky A. Briesacher ◽  
Antoinette Schoenthaler ◽  
...  
Keyword(s):  
Medication Adherence ◽  
African Americans ◽  
Inner City ◽  
Racial Discrimination ◽  
Trust In Physicians

Probing the Paradoxical Pattern of Cigarette Smoking among African-Americans: Low Teenage Consumption and High Adult Use

1995 ◽  
Vol 25 (4) ◽  
pp. 307-320 ◽  
Author(s):  
William Feigelman ◽  
Julia Lee
Keyword(s):  
African American ◽  
African Americans ◽  
Secondary Analysis ◽  
African American Adolescents ◽  
Past Research ◽  
Use Patterns ◽  
African American Adults ◽  
Gender And Age ◽  
And Gender ◽  
Low Prevalence

Based on secondary analysis of the 1990 California Tobacco Survey, of 24,296 adult and 7,767 adolescent respondents, this study investigates the enigmatic results established by past research, of comparatively low prevalence rates of smoking among African-American adolescents and high use patterns for African-American adults. Findings support the crossover hypothesis claiming that more young adult White smokers successfully relinquish cigarette use than same aged African-Americans. When Whites and Blacks were grouped according to gender and age, findings showed African-American males between ages eighteen to twenty-four and females between ages twenty-five and forty-four were less likely to be among the ranks of former smokers than their same aged and gender White counterparts. The findings suggest that targeting these groups for more antismoking information and for opportunities to participate in smoking cessation programs may be helpful to reduce the higher smoking rates now found among African-American adults.

Sign in / Sign up

Export Citation Format

Share Document